DermTech
Stock Forecast, Prediction & Price Target
DermTech Financial Estimates
DermTech Revenue Estimates
DermTech EBITDA Estimates
DermTech Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | ||
Revenue
% change YoY
| $11.83M N/A | $14.51M 22.63% | $15.29M 5.35% | Avg: $17.4M Low: $17.4M High: $17.4M avg. 13.75% | Avg: $25.4M Low: $25.4M High: $25.4M avg. 45.97% | ||
Net Income
% change YoY
| $-76.97M N/A | $-113.71M -47.73% | $-100.88M 11.28% | Avg: $-74.42M Low: $-67.89M High: $-67.89M avg. 26.23% | Avg: $-78.5M Low: $-34.92M High: $-34.92M avg. -5.47% | ||
EBITDA
% change YoY
| $-76.31M N/A | $-118.30M -55.03% | $-97.89M 17.25% | Avg: $-17.4M Low: $-17.4M High: $-17.4M avg. 82.22% | Avg: $-25.4M Low: $-25.4M High: $-25.4M avg. -45.97% | ||
EPS
% change YoY
| -$2.66 N/A | -$3.79 -42.48% | -$3.09 18.46% | Avg: -$2.08 Low: -$2.08 High: -$2.08 avg. 32.68% | Avg: -$1.07 Low: -$1.07 High: -$1.07 avg. 48.55% | ||
Operating Expenses
% change YoY
| $78.67M N/A | $118.81M 51.02% | $104.01M -12.45% | Avg: $94.63M Low: $94.63M High: $94.63M avg. -9.02% | Avg: $138.13M Low: $138.13M High: $138.13M avg. 45.97% | ||
FAQ
What is DermTech stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 10.37% in 2025-2026.
We have gathered data from 1 analysts. Their low estimate is -67.89M, average is -74.42M and high is -67.89M.
What is DermTech stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 29.86% in 2025-2026.
We have gathered data from 1 analysts. Their low revenue estimate is $17.4M, average is $17.4M and high is $17.4M.
What is DermTech stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 40.62% in 2025-2026.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$2.08, average is -$2.08 and high is $-2.08.
What is the best performing analyst?
In the last twelve months analysts have been covering DermTech stock. The most successful analyst is Sung Ji Nam.